Drug guidance
Acarbose for treating type 2 diabetes mellitus
Condition
Endocrine and metabolic
19 December 2022
Published on 19 Dec 2022
Last Updated on 19 Dec 2022
Guidance Recommendations
The Ministry of Health's Drug Advisory Committee has not recommended acarbose for inclusion on the MOH List of Subsidised Drugs for treating type 2 diabetes mellitus due to low clinical need and decreasing utilisation in local practice, unfavourable cost-effectiveness, and availability of multiple subsidised alternatives.
Acarbose for treating type 2 diabetes mellitus (19 December 2022) [PDF, 91 KB]